Compare Mutual Funds
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.05
-
NAV
₹22.60
-
Fund Started
06 Oct 2020
-
Fund Size
₹171.59 Cr
-
Exit Load
-
-
1 Year
15.17%
-
3 Year
20.12%
-
5 Year
12.73%
-
Equity
99.70%
-
Cash
0.02%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.90% |
Eli Lilly And Co | 5.70% |
Apollo Hospitals Enterprise Ltd. | 5.65% |
Divi's Laboratories Ltd. | 5.33% |
Max Healthcare Institute Ltd. | 5.30% |
Cipla Ltd. | 5.08% |
Dr. Reddy's Laboratories Ltd. | 4.92% |
Johnson & Johnson Ltd. | 4.17% |
Lupin Ltd. | 3.97% |
Torrent Pharmaceuticals Ltd. | 3.40% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
-
Launch Date
06 Oct 2020
-
